Paxil (paroxetine hydrochloride)

The selective serotonin-reuptake inhibitors (SSRI) known as Paxil (paroxetine hydrochloride) has been prescribed for patients as a treatment for depression, panic disorder, panic attacks, social anxiety disorder, obsessive-compulsive disorder, generalized anxiety disorder, posttraumatic stress disorder, and premenstrual dysphoric disorder.

On December 8, 2005, the United States Food and Drug Administration (FDA) issued the following comments: “The Food and Drug Administration today is alerting health care professionals and patients about early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy.” These FDA comments also stated the following: “The early results of two studies showed that women who took Paxil during the first three months of pregnancy were about one and a half to two times as likely to have a baby with a heart defect as women who received other antidepressants or women in the general population.” The FDA asked GlaxoSmithKline, the manufacturer of Paxil to change the pregnancy category from C to D.

If you live in California, took Paxil during pregnancy, and have a baby with serious heart disease, you should know that attorney and physician Paul J. Molinaro is available to answer your legal questions and help you determine whether you are entitled to compensation. You can reach Paul J. Molinaro, M.D. J.D. toll free at (888)MDJDLAW. The initial consultation is also free, and if Paul determines that you have a case, and you decide to hire Paul, he will represent you on a contingent basis.

Ratings and Reviews